Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
The Lancet. Oncology
Meric-Bernstam, Funda F; Hurwitz, Herbert H; Raghav, Kanwal Pratap Singh KPS; McWilliams, Robert R RR; Fakih, Marwan M; VanderWalde, Ari A; Swanton, Charles C; Kurzrock, Razelle R; Burris, Howard H; Sweeney, Christopher C; Bose, Ron R; Spigel, David R DR; Beattie, Mary S MS; Blotner, Steven S; Stone, Alyssa A; Schulze, Katja K; Cuchelkar, Vaikunth V; Hainsworth, John J